MyFinsight
Home
Blog
About
Contact
regn: the balance sheet
Download
Download image
Prepaid expenses and
other current assets
$595,600K
(44.56%↑ Y/Y)
Inventories
$3,254,400K
(7.83%↑ Y/Y)
Accounts receivable, net
$5,687,100K
(-6.88%↓ Y/Y)
Marketable securities
$5,937,200K
(-23.73%↓ Y/Y)
Cash and cash
equivalents
$2,506,400K
(24.58%↑ Y/Y)
Other noncurrent
assets
$1,673,100K
(60.41%↑ Y/Y)
Deferred tax assets
$3,846,700K
(27.58%↑ Y/Y)
Intangible assets, net
$1,380,900K
(23.28%↑ Y/Y)
Property, plant, and
equipment, net
$5,002,300K
(12.68%↑ Y/Y)
Marketable securities
$10,285,700K
(21.14%↑ Y/Y)
Total current assets
$17,980,700K
(-7.00%↓ Y/Y)
Total assets
$40,169,400K
(7.28%↑ Y/Y)
Total liabilities and
stockholders' equity
$40,169,400K
(7.28%↑ Y/Y)
Total stockholders'
equity
$30,957,800K
(5.56%↑ Y/Y)
Total liabilities
$9,211,600K
(13.50%↑ Y/Y)
Treasury stock, at cost
32.7 shares in 2025...
$17,944,400K
(26.44%↑ Y/Y)
Accumulated other
comprehensive income (loss)
$69,000K
(14.62%↑ Y/Y)
Retained earnings
$35,045,800K
(13.95%↑ Y/Y)
Other noncurrent
liabilities
$1,861,800K
(20.61%↑ Y/Y)
Deferred revenue
$219,200K
(5.69%↑ Y/Y)
Finance lease
liabilities
$720,000K
(0.00%↑ Y/Y)
Long-term debt
$1,985,500K
(0.08%↑ Y/Y)
Total current
liabilities
$4,425,100K
(20.87%↑ Y/Y)
Additional paid-in capital
$13,787,300K
(8.54%↑ Y/Y)
Common stock-Common
Stock
$100K
(0.00%↑ Y/Y)
Deferred revenue
$545,600K
(-13.01%↓ Y/Y)
Accrued expenses and
other current...
$2,975,700K
(17.32%↑ Y/Y)
Accounts payable
$903,800K
(81.74%↑ Y/Y)
Back
Back
Balance Sheet
source: myfinsight.com
REGN_BIG copy-svg-svg-svg
REGENERON PHARMACEUTICALS, INC. (REGN)
REGN_BIG copy-svg-svg-svg
REGENERON PHARMACEUTICALS, INC. (REGN)